Anaïs Corma-Gómez, Alfonso Cabello, Eva Orviz, Miguel Morante-Ruiz, Oskar Ayerdi, Aws Al-Hayani, Ana Muñoz-Gómez, Ignacio De Los Santos, Cristina Gómez-Ayerbe, David Rodrigo, Sandra De la Rosa Riestra, Sergio Reus-Bañuls, Ana Silva-Klug, María José Galindo, Marta Santos, Miriam Serrano-Fuentes, Naya Faro-Míguez, Inés Pérez-Camacho, Diana Corona-Mata, Luis Morano, Miguel Ángel López-Ruz, Marta Montero, Blanca Anaya-Baz, Dolores Merino, Antonia Castillo-Navarro, Juan A Pineda, Juan Macías
To date, former research about the impact of HIV infection on mpox poor outcomes is still limited and controversial. Therefore, the aim of this study was to assess the impact of HIV on the clinical course of mpox, in a large population of patients from Spain. Nationwide case-series study. Patients from 18 Spanish hospitals, with PCR-confirmed mpox from April 27, 2022 to June 30, 2023 were included in this study. The main outcome was the development of long or complicated (LC) mpox, defined as: (i) duration of the clinical course ≥ 28 days, or; (ii) disseminated disease, or: (iii) emergence of severe complications...
March 2024: Journal of Medical Virology